Albemarle (NYSE: ALB) reported Q1 EPS of $1.05, $0.08 better than the analyst estimate of $0.97. Revenue for the quarter came in at $722.1 million versus the consensus estimate of $682.55 million.

• Initiated $250 million accelerated share repurchase program, retiring approximately 1.9 million shares in the first quarter

Outlook

Our strong start to 2017 in Lithium and Bromine Specialties, and continued favorable outlooks in both businesses have made us more optimistic about full year 2017. Based on this we are raising our annual guidance as follows:

	Previous Outlook		Increase		Current Outlook
Net sales	$2.8 - $2.95 billion		$0.1 billion		$2.9 - $3.05 billion
Adjusted EBITDA	$800 - $840 million		$35 million		$835 - $875 million
Adjusted EPS (per diluted share)	$4.00 - $4.25		$0.20		$4.20 - $4.40

For earnings history and earnings-related data on Albemarle (ALB) click here.